Anti-HIV Agents

"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Descriptor ID	D019380
MeSH Number(s)	D27.505.954.122.388.077.088
Concept/Terms	Anti-HIV Agents Anti-HIV Agents Agents, Anti-HIV Anti HIV Agents Anti-AIDS Agents Agents, Anti-AIDS Anti AIDS Agents Anti-HIV Drugs Anti HIV Drugs Drugs, Anti-HIV AIDS Drugs Drugs, AIDS Anti-AIDS Drugs Anti AIDS Drugs Drugs, Anti-AIDS

Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]
Anti-Retroviral Agents [D27.505.954.122.388.077]
Anti-HIV Agents [D27.505.954.122.388.077.088]

Below are MeSH descriptors whose meaning is related to "Anti-HIV Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.

Bar chart showing 87 publications over 19 distinct years, with a maximum of 10 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	2	2
2003	4	1	5
2004	5	1	6
2005	9	1	10
2006	6	1	7
2007	6	3	9
2008	7	0	7
2009	4	0	4
2010	5	3	8
2011	6	1	7
2012	4	0	4
2013	2	0	2
2014	1	0	1
2016	4	0	4
2017	1	0	1
2018	3	0	3
2019	2	0	2
2021	2	0	2
2022	3	0	3

Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.

Sonalkar S, McAllister A, Kete C, Fishman J, Frarey A, Short WR, Schreiber CA, Teitelman A. Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care. J Acquir Immune Defic Syndr. 2022 Jul 01; 90(S1):S129-S133.

View in: PubMed
Schafer JJ, Zimmerman M, Walshe C, Cerankowski J, Shimada A, Keith SW. Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide. Obesity (Silver Spring). 2022 Jun; 30(6):1197-1204.

View in: PubMed
Groves AK, Vadaketh J, Raziano VT, Nkwihoreze H, Short WR, Momplaisir F. Preexposure Prophylaxis Acceptability Among Pregnant Individuals and Implications for Human Immunodeficiency Virus Prevention. Obstet Gynecol. 2022 Apr 01; 139(4):537-544.

View in: PubMed
Dean LT, Chang HY, Goedel WC, Chan PA, Doshi JA, Nunn AS. Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA. AIDS. 2021 11 15; 35(14):2375-2381.

View in: PubMed
Baker Z, Javanbakht M, Moore J, Brosnan H, Squires K, Bunge K, Zimet G, Mensch B, Soto-Torres L, Kapogiannis B, Levy L, Hoesley C, Reirden D, Gaur A, Mayer K, Futterman D, Gorbach P. Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls. J Acquir Immune Defic Syndr. 2021 07 01; 87(3):944-950.

View in: PubMed
Genn L, Chapman J, Okatch H, Abell N, Marukutira T, Tshume O, Anabwani G, Gross R, Lowenthal ED. Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. AIDS Behav. 2019 Aug; 23(8):2130-2137.

View in: PubMed
Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 08 01; 33(10):1657-1662.

View in: PubMed
Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. AIDS Res Hum Retroviruses. 2018 08; 34(8):667-671.

View in: PubMed
Flynn PM. A broader look at adolescents with perinatal HIV. Nature. 2018 04; 556(7702):439-440.

View in: PubMed
Fowler MG, Flynn P, Aizire J. What is new in perinatal HIV prevention? Curr Opin Pediatr. 2018 02; 30(1):144-151.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement